NEW YORK, Feb. 8, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company announced today that Dr. Daniel Teper, Chief Executive Officer, will be presenting at the 18th annual BIO CEO & Investor Conference on Monday, February 8, 2016 at 5:30 PM local time at the Waldorf Astoria, Conrad Room, in New…